Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
905,258
-
Shares change
-
-35,872
-
Total reported value, excl. options
-
$150,577,291
-
Value change
-
-$5,847,660
-
Number of buys
-
43
-
Number of sells
-
-33
-
Price
-
$166.33
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q1 2024
125 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q1 2024.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 905,258 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (114,499 shares), Miller Investment Management, LP (103,226 shares), JPMORGAN CHASE & CO (81,289 shares), MORGAN STANLEY (70,858 shares), BANK OF AMERICA CORP /DE/ (50,288 shares), COMMONWEALTH EQUITY SERVICES, LLC (30,426 shares), Consolidated Investment Group LLC (29,700 shares), Royal Bank of Canada (28,993 shares), UBS Group AG (25,298 shares), and LPL Financial LLC (24,402 shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.